Displaying 1–25 of 62 results for Pharma IQ
CDMOs perfect the art of survival in today’s multi-product world
Streamlining Single-Use Processing on a Global Scale. Harmonization across global single-use processing operations delivers the efficiencies, cost savings and quality critical for success
Validation, calibration and qualification are extremely critical in pharmaceutical processes. Understanding them is necessary in order to meet cGMP guidelines.
GNC relies on its subsidiary, Nutra Manufacturing, to apply the company’s “quality first” principle to manufacturing
The advantages of near-infrared spectroscopy in pharmaceutical analysis
New tools help manufacturing automation contribute more to the bottom line
Gert Ragnarsson, Director of the Swedish Medical Projects Agency, discusses the biggest milestones in QbD over the last decade.
Effective quality management systems demand robust change control
Accurate answers to the wrong questions pose risks and unnecessarily drive up costs.
In the life of any drug product, the technology transfer of a process is a complex matter, made more complicated by the new definition of the Process Validation (PV) guidance issued by FDA in January 2011.
Forty-four percent of employees at major pharmaceutical companies are worried about losing their jobs this year, according to a new survey by the online community Pharma IQ.
MedImmunes approach may help take the blame off automation for plant startup delays.
B&W Tek Introduces Next Generation Handheld Raman Instrument for Material Verification in cGMP Compliant Facilities
Rapid microbiological methods continue to be developed in order to support or supplant compendial methods.
L2 measures 51 pharma brands on their digital IQs...how does your brand stack-up?
With real-time, wireless and other new monitoring technologies, pharma gains better control of temperature, pressure, humidity, and more.
A gradual transition to better C&Q practices is warranted, as is "getting rid of wasteful, bureaucratic practices that have developed over the years," says Abbott's David Dolgin.
Why can't QbD be, literally, as easy as pie?
Just as process validation can benefit from a QbD and a product lifecycle approach, so can analytical method validation and transfer
Individuals cannot perform well if there are basic problems with the systems in which they operate
Pharmaceutical Manufacturing introduces "Funny Pharm," sponsored by Paratherm Corp., featuring drawings by award-winning cartoonist Jerry King.
In this brief interview, John Albright discusses the specific benefits of Celsis platform.